Granules India Share Plunges 2% as USFDA Inspection Ends Without Observation
On July 3, Granules India shares gained 2% in early morning trade after the USFDA accomplished the pre-approval inspection (PAI) and the GMP audit. Granules...
Category : MARKETS
HDFC Bank Shares Zoomed on Merger with HDFC
On July 3, HDFC Bank’s share price gained over 2% after the lender proclaimed the completion of the merger with its parent HDFC Limited. The...
Vedanta Gains Amid Steel Business Review
On July 3, Vedanta’s share price zoomed in early trade as the company initiated a premeditated review of its steel and steel-making raw materials productions....
UltraTech Cement Share Hits High as Sales Growth Reflects Strong Demand
On July 3, UltraTech Cement rose per cent as its decent sales volume growth stimulated investors. At 9:19 am, the company’s shares were trading at...
Stocks Under F&O Ban: Indiabulls Housing Finance
Under the futures and options (F&O) segment, Indiabulls Housing Finance re-entered the ban list for trade on Monday, July 3, as per the National Stock...
Stocks in Focus: SBI, HDFC Twins, Reliance and Others
The GIFT Nifty, earlier known as SGX Nifty, recorded a positive debut on the international bourse, NSE IFSC, on Monday, indicating a positive opening for...
KNR Constructions Shares Zoomed as Subsidiary Bags Karnataka’s Road Project
On June 30, KNR Constructions shares jumped 1.5% after its subsidiary, KNR Kaveri Infra, entered into a contract with the National Highways Authority of India...
CreditAccess Grameen Shines 6% Amid Large Block Deals
On June 30, CreditAccess Grameen shares plunged 6% in the early trade post following large deals on the bourses. Around one crore shares, or a...
TD Power Systems Share Plunges 4% as 24% Stake Changes Hands
After large deals on the bourses, TD Power Systems shares gained 4% in early trade. Around 3.76 crore shares, or a 24% stake worth Rs...
Zydus Lifesciences Shares Gain on Tentative Nod from USFDA for Palbociclib Tablets
On June 30, Zydus Lifesciences rose and gained 1% in the early trade after the company received USFDA approval for breast cancer drugs. Zydus Lifesciences...
